Comparative evaluation of dose dependent efficacy of vitamin C, in relation to oxidative stress level in subjects with Oral Submucus Fibrosis
-
Published:2023-11-10
Issue:
Volume:12
Page:1455
-
ISSN:2046-1402
-
Container-title:F1000Research
-
language:en
-
Short-container-title:F1000Res
Author:
Patel ShraddhaORCID,
Patel Aditya,
Lohe Vidya,
Mohod Swapnil,
Urkude MinakshiORCID,
Patel Satyawansingh
Abstract
Background Oral submucus fibrosis (OSMF) has a 0.2-0.5 prevalence rate in India. The malignancy rate of OSMF was found to be 7.6%. The focus of pathogenesis is currently on reactive oxygen species levels which can rise to extremely high levels, exceeding the human body’s antioxidant defense system and causing oxidative stress that goes beyond physiological limitations. Since oxidative stress plays such a significant part in carcinogenesis and other degenerative diseases, it is fair to believe that antioxidants will help to reduce or even stop these processes. Vitamin C is known for its antioxidant properties which act as a lipid-soluble free radical scavenger in cell membranes. But in some of studies a paradoxical effect of antioxidant doses was found. Thus, the present study will be conducted to evaluate the dose dependent efficacy of Vitamin C level in relation to oxidative stress level in subjects of OSMF. Methods After informed consent, the patient’s examination will be conducted. For each individual, 5ml of the blood sample will be withdrawn under all the aseptic precautions and oxidative stress level will be assessed depending on MDA & SOD level in a central research laboratory. Depending on oxidative stress level patients will be divided into two groups. Group I - Moderate oxidative stress in OSMF SI less than 240 but more than 192 Group II - High Oxidative Stress in OSMF SI more than 240 Single and double doses of Vitamin C will be given to patients accordingly and the MDA & SOD levels will be calculated on day 30,90 days and on 180th day Conclusions Positive results of the study will give direction for choosing the correct dose of the antioxidant Vitamin C for OSMF depending on oxidative stress level.
Funder
Intramural Funding DMIHER
Publisher
F1000 Research Ltd
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference10 articles.
1. Malignant transformation rate in oral submucous fibrosis over a 17-year period.;P Murti;Community Dent. Oral Epidemiol.,1985 Dec
2. Role of free radicals and effectiveness of antioxidants in patients with OSMF & OLP- A Systematic Review.;V Naik;Int. J. Life Sci. Pharma. Res.,JANUARY 2018
3. The failure of cancer chemoprevention.;J Potter;Carcinogenesis.,2014 May
4. Cancer Chemoprevention: Evidence of a non linear dose response for the protective effectsof resveratrol in humans & mice.;L Cai;Transl. Med.,2015 July
5. Calcitonin& human renal calcium & electrolyte transport.;S Carney;Miner. Electrolyte Metab.,1997 Jan